Download Free Individualising Risk Book in PDF and EPUB Free Download. You can read online Individualising Risk and write the review.

This book investigates how paid care work and employment are being transformed by policies of social care individualisation in the context of new gig economies of care. Drawing on a case study of the creation of a new individualised care market under Australia’s National Disability Insurance Scheme the book provides important insights into possible futures for social care employment where care is treated as an individual consumer service. Bringing together sociological, political science and socio-legal approaches the book demonstrates how, in individualised care markets and with ineffective labour laws, risks of business and employment are devolved to frontline care workers. The book argues for an urgent re-evaluation of current policy approaches to care and for new regulatory approaches to protect workers in diverse forms of employment.
Drug overdose, driven largely by overdose related to the use of opioids, is now the leading cause of unintentional injury death in the United States. The ongoing opioid crisis lies at the intersection of two public health challenges: reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications. Chronic pain and opioid use disorder both represent complex human conditions affecting millions of Americans and causing untold disability and loss of function. In the context of the growing opioid problem, the U.S. Food and Drug Administration (FDA) launched an Opioids Action Plan in early 2016. As part of this plan, the FDA asked the National Academies of Sciences, Engineering, and Medicine to convene a committee to update the state of the science on pain research, care, and education and to identify actions the FDA and others can take to respond to the opioid epidemic, with a particular focus on informing FDA's development of a formal method for incorporating individual and societal considerations into its risk-benefit framework for opioid approval and monitoring.
Social isolation and loneliness are serious yet underappreciated public health risks that affect a significant portion of the older adult population. Approximately one-quarter of community-dwelling Americans aged 65 and older are considered to be socially isolated, and a significant proportion of adults in the United States report feeling lonely. People who are 50 years of age or older are more likely to experience many of the risk factors that can cause or exacerbate social isolation or loneliness, such as living alone, the loss of family or friends, chronic illness, and sensory impairments. Over a life course, social isolation and loneliness may be episodic or chronic, depending upon an individual's circumstances and perceptions. A substantial body of evidence demonstrates that social isolation presents a major risk for premature mortality, comparable to other risk factors such as high blood pressure, smoking, or obesity. As older adults are particularly high-volume and high-frequency users of the health care system, there is an opportunity for health care professionals to identify, prevent, and mitigate the adverse health impacts of social isolation and loneliness in older adults. Social Isolation and Loneliness in Older Adults summarizes the evidence base and explores how social isolation and loneliness affect health and quality of life in adults aged 50 and older, particularly among low income, underserved, and vulnerable populations. This report makes recommendations specifically for clinical settings of health care to identify those who suffer the resultant negative health impacts of social isolation and loneliness and target interventions to improve their social conditions. Social Isolation and Loneliness in Older Adults considers clinical tools and methodologies, better education and training for the health care workforce, and dissemination and implementation that will be important for translating research into practice, especially as the evidence base for effective interventions continues to flourish.
Individualization argues that we are in the midst of a fundamental change in the nature of society and politics. This change hinges around two processes: globalization and individualization. The book demonstrates that individualization is a structural characteristic of highly differentiated societies, and does not imperil social cohesion, but actually makes it possible. Ulrich Beck and Elisabeth Beck-Gernsheim argue that it is vital to distinguish between the neo-liberal idea of the free-market individual and the concept of individualization. The result is the most complete discussion of individualization currently available, showing how individualization relates to basic social rights and also paid employment; and concluding that in
Distance education is arguably one of the major developments in education during the 20th Century. This title explores the array of distance education theories and practices as they have been shaped by the late-20th Century and then positions these in terms of the contemporary circumstances of the 21st Century.
The research and debates surrounding curriculum, pedagogy and assessment are ever-growing and are of constant importance around the globe. With two volumes - containing chapters from highly respected researchers, whose work has been critical to understanding and building expertise in the field – The SAGE Handbook of Curriculum, Pedagogy and Assessment focuses on examining how curriculum is treated and developed, and its impact on pedagogy and assessment worldwide. The Handbook is organised into five thematic sections, considering: · The epistemology and methodology of curriculum · Curriculum and pedagogy · Curriculum subjects · Areas of the curriculum · Assessment and the curriculum · The curriculum and educational policy The SAGE Handbook of Curriculum, Pedagogy and Assessment’s breadth and rigour will make it essential reading for researchers and postgraduate students around the world.
Hippocrates famously advised doctors 'it is far more important to know what person the disease has than what disease the person has'. Yet 2,500 years later, 'personalised medicine', based on individual genetic profiling and the achievements of genomic research, claims to be revolutionary. In this book, experts from a wide range of disciplines critically examine this claim. They expand the discussion of personalised medicine beyond its usual scope to include many other highly topical issues, including: human nuclear genome transfer ('three-parent IVF'), stem cell-derived gametes, private umbilical cord blood banking, international trade in human organs, biobanks such as the US Precision Medicine Initiative, direct-to-consumer genetic testing, health and fitness self-monitoring. Although these technologies often prioritise individual choice, the original ideal of genomic research saw the human genome as 'the common heritage of humanity'. The authors question whether personalised medicine actually threatens this conception of the common good.
This book explores personal responses to risk from a social psychological framework.
The book covers the concepts, techniques and strategies of oncoplastic breast surgery and reconstruction for breast cancer patients. It includes contemporary surgical procedures with step-by-step illustrations, pre-operative and post-operative considerations, pearls and pitfalls shared from the personal experiences and surgical practices of the individual authors. Experienced authors with diverse backgrounds and an in-depth understanding of the domains are involved in curating the content of the book. This book mainly focuses on practical tips and surgical techniques to reach a broad spectrum of surgeons practicing breast surgery from low and middle-income countries. It provides both the scientific basis and practical tips from experienced surgeons in the field. Breast cancer is an emerging major public health problem in low and middle-income countries. While the surgical approach to breast cancer has witnessed a major shift from mastectomy to breast conservation, oncoplasty and reconstruction in western countries, the field of breast surgery is still evolving in low and middle-income countries. Barriers to adopting newer surgical approaches include socio-cultural factors, disease-related factors, resource-related factors and availability of expertise. This book fills the gap and helps surgeons in low and middle-income countries in adapting contemporary breast surgical techniques into their day-to-day practice. This book will be relevant for surgical oncologists, breast and endocrine surgeons, general surgeons practicing breast surgery and plastic surgeons. Additionally, it will serve as a resource book for residents and fellows from general surgery, surgical oncology, breast surgery and plastic surgery streams.
The winner of the 2020 British Insurance Law Association Book Prize, this timely, expertly written book looks at the legal impact that the use of 'Big Data' will have on the provision – and substantive law – of insurance. Insurance companies are set to become some of the biggest consumers of big data which will enable them to profile prospective individual insureds at an increasingly granular level. More particularly, the book explores how: (i) insurers gain access to information relevant to assessing risk and/or the pricing of premiums; (ii) the impact which that increased information will have on substantive insurance law (and in particular duties of good faith disclosure and fair presentation of risk); and (iii) the impact that insurers' new knowledge may have on individual and group access to insurance. This raises several consequential legal questions: (i) To what extent is the use of big data analytics to profile risk compatible (at least in the EU) with the General Data Protection Regulation? (ii) Does insurers' ability to parse vast quantities of individual data about insureds invert the information asymmetry that has historically existed between insured and insurer such as to breathe life into insurers' duty of good faith disclosure? And (iii) by what means might legal challenges be brought against insurers both in relation to the use of big data and the consequences it may have on access to cover? Written by a leading expert in the field, this book will both stimulate further debate and operate as a reference text for academics and practitioners who are faced with emerging legal problems arising from the increasing opportunities that big data offers to the insurance industry.